Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.

Ludovico Gennaro CobuccioMarie LaurentCeline GardiolRahel WampflerSven PoppertNicolas SennGilles ÉperonBlaise GentonIsabella LocatelliSerge Vallière

Published in: Journal of travel medicine (2022)

Among patients infected with Blastocystis sp., metronidazole, compared with placebo, was not better in improving gastrointestinal symptoms, irrespective of subtype or microscopically undetected coinfection with other protozoa.

Keyphrases

placebo controlled
double blind
phase iii
phase ii
clinical trial
study protocol
phase ii study
open label
randomized controlled trial
radiation therapy
sleep quality
physical activity